Poor medication adherence in clinical trials: Consequences and solutions
Breckenridge A., Aronson JK., Blaschke TF., Hartman D., Peck CC., Vrijens B.
Poor adherence to medicines in clinical trials can undermine the value of the trials; for example, by compromising estimates of the benefits and risks of a medicine. In this article, we highlight such consequences and also discuss approaches to tackle this problem.